BACKGROUNDS: Nonalcoholic fatty liver disease (NAFLD) has been linked to
cardiovascular disease (CVD) but it is largely unknown if such a relationship between …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, with a global
prevalence estimated at approximately 25%. NAFLD is also the leading cause of liver …

Abstract Background and Aim Non‐alcoholic fatty liver disease (NAFLD) is a multisystem
disease associated with an increased risk of cardiovascular disease (CVD), diabetes, and …

Nonalcoholic fatty liver disease (NAFLD) refers to a wide spectrum of liver damage, ranging
from simple steatosis to nonalcoholic steatohepatitis (NASH), advanced fibrosis, and …

The underlying mechanism and pathogenesis of NAFLD remain elusive despite ongoing
researches to make significant advances in the understanding of its natural history …

Abstract Background/Aims: Fatty liver is the hepatic component of the metabolic syndrome.
Insulin resistance, the pathogenic driver of the metabolic syndrome, refers to a constellation …

Nonalcoholic fatty liver disease (NAFLD) is now the leading cause of chronic liver disease
worldwide with a strong association with metabolic syndrome. NAFLD is truly a systemic …

BACKGROUND & AIMS: To estimate the prevalence of non-alcoholic fatty liver disease
(NAFLD) in type 1 diabetic individuals, and to evaluate whether NAFLD is associated with …

As the epidemics of obesity and type 2 diabetes mellitus increase worldwide, the prevalence
of non-alcoholic fatty liver disease (NAFLD) is increasing proportionately. The subtype of …

Aims/hypothesis Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum
ranging from simple steatosis to non-alcoholic steatohepatitis (NASH): NAFLD causes an …